Related Experiment Video
Updated: Feb 17, 2026

Use of Magnetic Resonance Imaging and Biopsy Data to Guide Sampling Procedures for Prostate Cancer Biobanking
Published on: October 10, 2019
Diagnostic evaluation of magnetization transfer and diffusion kurtosis imaging for prostate cancer detection in a
Tristan Barrett1,2,3, Mary McLean4, Andrew N Priest5
1Department of Radiology, University of Cambridge, Cambridge, UK. tb507@medschl.cam.ac.uk.
Objective:
To evaluate diffusion kurtosis imaging (DKI) and magnetisation transfer imaging (MTI) compared to standard MRI for prostate cancer assessment in a re-biopsy population.
Methods:
Thirty-patients were imaged at 3 T including DKI (Kapp and Dapp) with b-values 150/450/800/1150/1500 s/mm2 and MTI performed with and without MT saturation. Patients underwent transperineal biopsy based on prospectively defined MRI targets. Receiver-operating characteristic (ROC) analyses assessed the parameters and Wilcoxon-signed ranked test assessed relationships between metrics.
Results:
Twenty patients had ≥ 1 core positive for cancer in a total of 26 MRI targets (Gleason 3+3 in 8, 3+4 in 12, ≥ 4+3 in 6): 13 peripheral (PZ) and 13 transition zone (TZ). The apparent diffusion coefficient (ADC) and Dapp were significantly lower and the Kapp and MT ratio (MTR) significantly higher in tumour versus benign tissue (all p ≤ 0.005); ROC values 0.767-1.000. Normal TZ had: lower ADC and Dapp and higher Kapp and MTR compared to normal PZ. MTR showed a moderate correlation to Kapp (r = 0.570) and Dapp (r = -0.537) in normal tissue but a poor correlation in tumours. No parameter separated low-grade (Gleason 3+3) from high-grade (≥ 3+4) disease for either PZ (p = 0.414-0.825) or TZ (p = 0.148-0.825).
Conclusion:
ADC, Dapp, Kapp and MTR all distinguished benign tissue from tumour, but none reliably differentiated low- from high-grade disease.
Key Points:
• MTR was significantly higher in PZ and TZ tumours versus normal tissue • K app was significantly lower and D app higher for PZ and TZ tumours • There was no incremental value for DKI/MTI over mono-exponential ADC parameters • No parameter could consistently differentiate low-grade (Gleason 3+3) from high-grade (≥ 3+4) disease • Divergent MTR/DKI values in TZ tumours suggests they offer different functional information.
Insights
Diffusion kurtosis imaging (DKI) and magnetisation transfer imaging (MTI) show promise in distinguishing prostate tumors from benign tissue. However, these advanced MRI techniques cannot reliably differentiate between low- and high-grade prostate cancer.
Area of Science:
- Radiology
- Oncology
- Medical Imaging
Background:
- Prostate cancer assessment often requires re-biopsy, which can be invasive.
- Advanced MRI techniques like DKI and MTI may improve diagnostic accuracy.
Purpose of the Study:
- To compare the efficacy of DKI and MTI against standard MRI for prostate cancer detection in patients undergoing re-biopsy.
- To evaluate the ability of these advanced MRI techniques to differentiate tumor characteristics.
Main Methods:
- Thirty patients underwent 3 Tesla MRI including DKI (Kapp, Dapp) and MTI (with/without saturation).
- Patients had transperineal biopsy targeting MRI-identified lesions.
- ROC analyses and Wilcoxon-signed ranked tests were used to assess imaging parameters.
Main Results:
- Apparent diffusion coefficient (ADC) and Dapp were lower, while Kapp and MT ratio (MTR) were higher in tumors versus benign tissue (p ≤ 0.005).
- Normal transition zone (TZ) tissue differed from peripheral zone (PZ) tissue in ADC, Dapp, Kapp, and MTR.
- No significant difference was found between low-grade (Gleason 3+3) and high-grade (≥ 3+4) disease using any parameter.
Conclusions:
- DKI and MTI parameters (ADC, Dapp, Kapp, MTR) effectively distinguish prostate tumors from benign tissue.
- These advanced MRI techniques do not reliably differentiate between low- and high-grade prostate cancer.
- Further research is needed to explore the potential of divergent MTR/DKI values in TZ tumors.
Related Concept Videos
Imaging Studies IV: Magnetic Resonance Imaging
Magnetic Resonance Imaging

